Warfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis. [electronic resource]
Producer: 20110214Description: 135; author reply 135-6 p. digitalISSN:- 1538-3687
No physical items for this record
Publication Type: Comment; Letter; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.